Precigen, Inc. (DUS:I5X) Financings

Precigen, Inc.

Financings

RaiseDate
Private placement of 8.00% Series A Convertible Perpetual Preferred Stock and warrants
Announced: US$79M · Warrants at US$0.75
Buyers: Patient Capital Management (led the private placement through affiliates); Bill Miller; Randal J. Kirk
Insiders: Randal J. Kirk, executive chairman of the board of directors, participated
Use of proceeds: Working capital and general corporate purposes
Dec 27, 2024

Read by 6ix AI from the company's releases